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Aqueous extracts of Zingiber officinale rhizomes were studied to evaluate their antidiabetic effects on 
protein glycation and on the diffusion of glucose in vitro in the present study. Zingiber officinale rhizome 
aqueous extract were examined at concentrations of 5, 10, 20 and 40 g/L. The antidiabetic effects were 
found to be dose-dependent. Antidiabetic potential of Zingiber officinale was mainly through inhibition 
of the glucose diffusion and to a limited extent by reducing the glycation. However, further studies are 
needed to determine in vitro effects of therapeutic potential by restraining postprandial glucose absorptions 
and plasma protein glycations in diabetic subjects.
Uniterms: Zingiber officinale/pharmacognosy. Zingiber officinale/antidiabetic effects/in vitro study. 
Diabetes mellitus. Hyperglycemia. Proteins/glycation. Glucose/diffusion in vitro.
Extratos aquosos de rizomas Zingiber officinale foram estudados para avaliar os seus efeitos antidiabéticos 
em glicação de proteínas e sobre a difusão de glicose in vitro, no presente estudo. Extratos aquosos de 
Zingiber officinale foram examinados nas concentrações de 5, 10, 20 e 40 g extrato de planta/L. Os efeitos 
antidiabéticos observados eram dependentes da dose. O potencial antidiabético de Zingiber officinale 
se verificou, principalmente, através da inibição da difusão de glicose e, em menor extensão, através 
da redução da glicação. Estudos adicionais são necessários para elucidar se efeitos in vitro representam 
potencial terapêutico, restringindo a absorção de glicose pós-prandial e a glicação de proteínas plasmáticas 
em indivíduos diabéticos.
Unitermos: Zingiber officinale/farmacognosia. Zingiber officinale/efeitos antidiabéticos/estudo in vitro. 
Diabetes mellitus. Hiperglicemia. Proteinas/glicação. Glicose/difusão in vitro.
INTRODUCTION
Incubation of proteins with glucose leads to non-
-enzymatic glycation and formation of amadori products 
known as an early glycation product. Non-enzymatic 
glycation of proteins or Maillard reaction is increased 
in diabetes mellitus due to hyperglycemia and leads to 
several complications such as blindness, hepatic and 
cardiovascular diseases, nerve damage and kidney failure 
(Hussain et al., 2008, 2011; Chen et al., 2011). Normal 
glucose homeostasis involves glucose absorption via the 
gut, production by the liver and utilization by nearly all 
tissues in the body (Kahn, 1992). Diabetes mellitus (DM), 
a metabolic disorder caused by insufficient or inefficient 
insulin secretary response is characterized by hypergly-
cemia.
Recently, much attention has been focused on natu-
ral and synthetic glycation inhibitors to delay the onset 
or progression of diabetic complications (Rahman et al., 
2009; Peng et al., 2011). The scope for the discovery and 
development of new anti-diabetic therapies from nature’s 
pharmacy is vast and merits corresponding consideration.
Diet has always been recognized as a corner stone 
in the management of diabetes mellitus. Spices are known 
to exert several antidiabetic influences (Srinivasan, 2005). 
Given the large number of plants reputed to possess anti-
diabetic properties (Saraswat et al., 2010; Ugwuja et al., 
2010; Jafri et al., 2011), only a few have received equitable 
scientific and medical scrutiny in terms of their antiglycation 
activities. Another often ignored mechanism of anti-diabetic 
phytomedicines is the role of viscous polysaccharides that 
control blood glucose concentration by inhibiting intestinal 
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glucose absorption (Hagander et al., 1984; Edwards et al., 
1988; Groop et al., 1993; Gallagher et al., 2003).
Zingiber officinale (ginger) rhizome is one of the 
classic examples of an herb used for not only culinary 
preparations but also for unique therapeutic significance ow-
ing to its antioxidant, antimicrobial, anti-inflammatory and 
chemoprotective potential (Afzal et al., 2001; El-Ghorab 
et al., 2010; Ghasemzadeh et al., 2010; Rani et al., 2011; 
Al-Suhaimi et al., 2011; Baliga et al., 2011; Butt, Sultan, 
2011; Rehman et al., 2011). Although several studies have 
mentioned antidiabetic activity of Zingiber officinale (Gro-
ver et al., 2002; Akhani et al., 2005; Kelble, 2005; Al-Amin 
et al., 2006; Büyükbalci, Sedef, 2008; Islam, Choi, 2008; 
Abd-Elraheem et al., 2009; Saraswat et al., 2009; Ogbera 
et al., 2010; Saraswat et al., 2010; Madkor et al., 2011; 
Ramudu et al., 2011; Rani et al., 2011), no data is available 
on protein glycation and glucose absorption inhibitory 
potential of native Zingiber officinale rhizomes at national 
level. The present study was undertaken to investigate the 
antidiabetic effects of Zingiber officinale in terms of glucose 
diffusion and glycation inhibition.
MATERIAL AND METHODS
Extract preparation
Zingiber officinale rhizomes were collected from 
Botanical garden, University of Agriculture, Faisalabad, 
Pakistan during March, 2011. The collected rhizomes 
were homogenized to fine powder and were stored at room 
temperature. Aqueous extracts of roots were prepared by 
cold infusion. One gram powdered material was infused 
for 15 min in 40 mL of boiling distilled water and then 
filtered, dried under vacuum and stored at -20 oC till further 
analysis. Antidiabetic activity of Zingiber officinale was 
determined by two methods:
Glycation inhibition
To study the effect of Zingiber officinale on protein 
glycation process, fifteen combinations of 0.075 M phos-
phate buffer saline (PBS) with glucose (G1: 5.5, G2: 25, 
G3: 50 mM), Z. officinale (I1:5, I2:10, I3:20, I4: 40 g/L as 
inhibitor) and protein (bovine albumin) were incubated at 
37 oC for five weeks (Table I). Samples were analyzed after 
3rd and 5th weeks of incubation. Glucose concentrations 
were measured and samples were dialyzed to remove free 
glucose. Free glucose is the major hindrance in estima-
tion of glycation level. Post-dialysis, glucose was again 
estimated to confirm final glucose levels. Total proteins 
in all samples after dialysis were determined by biuret 
method (Gornall et al., 1949). Thiobarbituric Acid (TBA) 
colorimetric test was used for the determination of both 
enzymatic glycation (EG) and non-enzymatic glycation 
(NEG) as described by Furth (1988).
Non-enzymatic and enzymatic glycation (collective)
One mL of dialyzed sample (total protein = 
10 mg/mL) was used for non-enzymatic and enzymatic 
glycation. Three test tubes were arranged for each of re-
duced and non-reduced samples. 0.1 mL of NaBH4 was 
added in reduced samples and 0.1 mL of 0.01 N NaOH was 
added to non-reduced samples. All test tubes were left for 
30 minutes at 37 oC. After half an hour, 1 drop of 1N HCl 
was added in each test tube, followed by addition of 0.5 mL 
oxalic acid. Tubes were capped and autoclaved for half an 
hour at 124 oC (ll5 Lb/inch2 pressure). Tubes were cooled 
to room temperature and then placed in ice. In each tube, 
0.5 mL of 40% trichloroacetic acid (chilled) was added. 
Afterwards, samples were centrifuged for 15 minutes at 
15000 rpm. Supernatant (1.5 mL) was mixed with 0.5 mL 
freshly prepared TBA. Later on, the samples were incubated 
at 37 oC in water bath for 15 minutes and absorbance was 
determined at 443 nm.
Enzymatic glycation
For determination of enzymatic glycation (EG), 
0.1 mL NaOH (0.01 N) containing 400 molar excess of 
NaBH4 was used. After the reduction, the glycation level 
was determined by the same process as mentioned above. 
Non-enzymatic glycation(NEG) was determined as follows:
NEG = (NEG + EG) – EG
TABLE I - Different combinations used for glycation inhibition 
study
Sr.# Combinations Sr.# Combinations
1 P + G1 9 I2 + P + G3
2 P + G2 10 I3 + P + G1
3 P + G3 11 I3 + P + G2
4 I1 + P + G1 12 I3 + P + G3
5 I1 + P + G2 13 I4 + P + G1
6 I1 + P + G3 14 I4 + P + G2
7 I2 + P + G1 15 I4 + P + G3
8  I2 + P + G2
P: Protein (Bovine albumin), G: Glucose, I: Inhibitor (Zingiber 
officinale), G1: 5.5 mM, G2: 25 mM, G3: 50 mM; I1:5 g/L, 
I2:10 g/L, I3:20 g/L, I4:40 g/L
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Glucose diffusion inhibition
The potential of ginger rhizome extracts to inhibit 
glucose diffusion into the external solution was investi-
gated at set time intervals (Gallagher et al., 2003). In a di-
alysis tube (6 cm×15 mm), 15 mL of a solution of glucose 
and NaCl (0.15 M) was introduced and the appearance of 
glucose in the external solution was measured. The sealed 
tube was placed in a centrifuge tube containing 45 mL of 
0.15 M NaCl. The tube was placed on an orbital shaker at 
room temperature. Glucose concentrations were measured 
by glucose oxidase kit method. Incremental areas under the 
glucose curves (AUC) were calculated by trapezoidal rule.
Statistical analysis
All data were expressed as mean ± SD and % age 
± SD of triplicate measurements. Student’s t-test was 
performed by Statistical Package for the Social Sciences 
(SPSS Inc. Chicago, IL, USA) software (version 15.0) 
with level of significance set at p < 0.05.
RESULTS
Results of antiglycation potential of Zingiber of-
ficinale are presented in Figure 1.
For controls, 50 mM (G3) glucose exhibited maxi-
mum glycation (3.97 mol glucose/mol protein) after five 
weeks. G1 (5.5 mM) and G2 (25 mM) also showed optimal 
FIGURE 1 - Effect of aqueous extracts of Z. officinale rhizome on glycation levels. Data are mean ± SD for triplicate measurements. 
P: Protein (Bovine albumin), G: Glucose, I: Inhibitor (Zingiber officinale), G1: 5.5 mM, G2: 25 mM, G3: 50 mM; I1:5 g/L, I2:10 
g/L, I3:20 g/L, I4:40 g/L
glycations (3.64 and 3.72 mol glucose/mol protein). Aque-
ous extract of 5g/L ginger (I1) reduced glycation levels for 
G1 (5.5 mM), G2 (25 mM) and G3 (50 mM) as compared to 
controls and glycation concentrations after 5th week were 
3.52, 3.48 and 3.44 mol glucose/mol protein, respectively. 
Likewise, aqueous extract of 10 g/L (I2) ginger lowered 
glycation levels for G1, G2 and G3 up to 3.33, 3.28, 3.19 
mol glucose/mol protein, respectively in the final week. 
Doubling the extract concentrations (I3) as compared to 
I2 further decreased glycation levels (for G1: 3.01, G2: 
2.97, G3: 2.84 mol glucose/mol protein). Percentage 
differences in glycation of various combinations from 
controls reduced significantly. Glycation reduction by 
I1 was not significant for any combination after 3rd or 5th 
week analysis. I2 showed significant decrease with G3 in 
5th week. Optimum inhibitor concentrations (I3 and I4) 
indicated significant decline in glycation measurements 
after 5th week. Most striking observation was maximum 
glycation inhibition by I4 (Table II).
A simple model was used to investigate glucose ab-
sorption inhibition by Zingiber officinale. After 30 h, in the 
control (without plant extract) glucose movement out of 
dialysis reached a peak level and glucose concentration in 
the external solution was 21.20 mmol/L. Different concen-
trations of Z. officinale extracts were used to investigate 
the dose-dependent effects on glucose diffusion. The plant 
extracts exhibited a concentration-dependent inhibitory 
effect on glucose movement (Figure 2).
The effect of variable inhibitor concentrations on 
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glucose diffusion out of the dialysis tube was also assessed 
in terms of area under curve (AUC) (Table III).
Extract having 20 and 40 g/L ginger were the most 
effective inhibitors of glucose movement in the model 
system. In the presence of 20 g/L inhibitor, glucose dif-
fusion was significantly decreased and external glucose 
concentrations were 15.1 mmol/L after 30 h. This repre-
sents 32.1% decrease in total glucose diffusion compared 
to control (p< 0.05). Similarly, 40 g/L ginger revealed 
more than 45% decrease in the glucose movement (p< 
0.05) compared to control with a mean external glucose 
concentration of 12.4 mmol/L after 30 h. Extracts contain-
ing I1 and I2 inhibitor concentrations were least effective. 
These extracts demonstrated a mean external glucose 
concentration of 17.20 and 15.80 mmol/L after 30 h. The 
external glucose concentrations after 30 h were greater at 
5 g/L compared to 40 g/L (17.2 vs 12.4 mmol/L respec-
tively, p< 0.05). Aqueous ginger extracts demonstrated 
significant inhibitory effects on glucose movement into 
external solution across dialysis membrane compared to 
control. For all the test samples, the overall rates of glucose 
movement into external solution were lower than that of 
control. The results underline the importance of Zingiber 
officinale against the diabetic conditions mainly through 
inhibition of the glucose absorption and to a lesser extent 
by its antiglycating potential. The therapeutic use of nutri-
ents needs further exploration for the prevention or delay 
of diabetic complications.
DISCUSSION
Nonenzymatic glycation of proteins or Maillard 
reaction is increased in diabetes mellitus due to hypergly-
cemia (Hussain et al., 2008; Cárdenas-León et al., 2009; 
Hussain et al., 2010; Hussain et al., 2011; Schalkwijk, 
Miyata, 2012). Numerous synthetic and natural com-
TABLE II- Percent decrease in glycation levels at different 
concentrations of plant extracts
Combination
% Decrease in 
glycation after 3 
weeks1
% Decrease in 
glycation after 5 
weeks1
Control (no extract)
     G1
     G2
     G3 
Plant extract (I1)
     G1
     G2
     G3
Plant extract (I2)
     G1
     G2
     G3
Plant extract (I3)
     G1
     G2
     G3
Plant extract (I4)
     G1
     G2
     G3
-
-
-
2.89 ± 0.08
3.68 ± 0.18
10.69 ± 0.05
2.57 ± 0.03
7.02 ± 0.06
10.38 ± 0.01
8.04 ± 0.04
15.5 ± 0.20
17.61 ± 0.01
21.22 ± 0.06*
26.76 ± 0.03*
24.84 ± 0.02*
-
-
-
3.30 ± 0.06
6.45 ± 0.02
13.35 ± 0.03
8.52 ± 0.02
11.83 ± 0.01
19.65 ± 0.02*
17.31 ± 0.01*
20.16 ± 0.01*
28.46 ± 0.03*
27.47 ± 0.01*
27.69 ± 0.02*
31.99 ± 0.01*
Data are % age ± SD for triplicate measurements. 
G: Glucose, I: Inhibitor (Zingiber officinale), G1: 5.5 mM, G2: 
25 mM, G3: 50 mM; I1:5 g/L, I2:10 g/L, I3:20 g/L, I4:40 g/L
*p < 0.05
1Percentage decrease in glycation in comparison to control.
FIGURE 2- Effect of aqueous extracts of Z. officinale on glucose 
diffusion.
TABLE III - Effect of different concentrations of plant extract on 
glucose diffusion to external solution
Sample AUC (mmol/L 
glucose after 30 h)1
% Decrease in 
Diffusion2
Control (no extract)
Plant extract
   I4 (40 g/L) 
   I3 (20 g/L) 
   I2 (10 g/L) 
   I1 (5 g/L)
416.10 ± 1.52
221.70 ± 2.07
282.45 ± 0.86 
309.60 ± 12.36
342.60 ± 7.25
-
46.71 ±*
32.1 ±*
25.59 ±*
17.66 ±*
Data are mean ± SD or % ± SD for triplicate measurements.
p < 0.05
1AUC: (area under the curve) was calculated using total glucose 
diffusion during 30 h incubation period as described in the 
methods section.
2Percentage decrease in movement of glucose into the external 
solution in comparison to control.
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pounds with different glycation inhibition mechanisms 
are reviewed in literature. However, owing to the side 
effects of synthetic molecules, all future expectations rely 
on natural antiglycation compounds (Peng et al., 2011).
Ginger can lower the blood glucose, improve ac-
tivities of mitochondrial enzymes and could be used as 
a nephro-protective supplement particularly to reverse 
diabetic complications (Saraswat et al., 2010; Ramudu et 
al., 2011). The potential effects of Zingiber officinale in 
terms of protein glycation and glucose diffusion inhibition 
were evaluated in the present study.
Thiobarbituric colorimetric assay was used to es-
tablish the concentration and time dependent inhibition of 
protein glycation by ginger. Four different concentrations 
of aqueous extracts of ginger rhizomes were used to de-
termine the time-dependent changes in protein glycation 
levels after three and five weeks of incubation at 37 °C in 
the presence and absence of plant extracts. Ginger extract 
concentrations of I3 (20 g/L) and I4 (40 g/L) showed sig-
nificant percent reduction (28.46 ± 0.03 - 31.99 ± 0.01) 
in NEG. Hence the extracts showed a dose-dependent 
inhibition of protein glycation. Previously, 63% glycation 
inhibition by ginger at the concentration of 1.0 mg/mL was 
reported (Saraswat et al., 2009).
Reduction in glycation can be justified by the fact 
that non-enzymatic glycation is the covalent binding of 
reducing sugars to α- or ε- amino groups on protein. This 
glycation lowering activity can be linked to the presence 
of various phenolic components in ginger rhizomes. The 
pungent fractions of ginger, namely gingerols, shogaols, 
paradols, and volatile constituents like sesquiterpenes 
and monoterpenes, are mainly attributed to the health-
enhancing perspectives of ginger (Al-Amin et al., 2006; 
Ojewole, 2006; Islam, Choi, 2008; Butt, Sultan, 2011). 
The NEG inhibitory activity of ginger depends, at least in 
part, on its ability to trap reactive carbonyl intermediates 
in NEG/AGE formation, thereby inhibiting the chemical 
modification of proteins. In terms of preventing protein 
and sugar cross-links, the aqueous extracts of ginger 
showed 30-80% reductions (Saraswat et al., 2009).
The above-mentioned inferences confirm the ability 
of Z. officinale extracts to lower the protein glycation in an 
empirical in vitro manner by TBA assay. Other chemical 
methods and in vivo models might not be able to produce 
similar reductions in protein glycation process by these 
extracts.
Incubation period also affected glycation process. 
The percentage inhibitions in NEG after third week be-
came significant when incubations were prolonged to five 
weeks indicating decline in potential glycation with time. 
In recent years, much interest has been focused on the role 
of viscous polysaccharides in the treatment of diabetes 
mellitus. The action of the polysaccharides in reducing 
postprandial hyperglycemia is thought to be related to 
their viscosity. Viscous polysaccharides may delay glucose 
absorption probably by impairing the access of luminal 
contents to the absorptive epithelium (Hagander et al., 
1984; Edwards et al., 1988; Groop et al., 1993).
Ginger extracts also prevented or reduced glucose 
movement and evaluated percent decrease predicted the ac-
tion of the plant polysaccharides on hyperglycemia in vivo. 
High concentration extracts (20, 40 g/L) showed greater 
percent decrease (32%-46.7%) in glucose movement. The 
results suggested that the part of the antihyperglycemic ac-
tions of ginger may be by decreasing glucose absorption in 
vivo. The main mechanism concerning the role of dietary 
fiber in lowering postprandial serum glucose is the viscosity 
of different dietary fibers in hampering diffusion of glucose 
and postponing absorption and digestion of carbohydrates 
as these bind glucose and resultantly decrease the concen-
tration of available glucose in the small intestine (Ou et al., 
2001). Gallagher et al. (2003) studied the ability of differ-
ent plants to inhibit glucose diffusion. They reported that 
agrimony and avocado represented the greatest inhibitory 
effect on glucose diffusion (more than 60%). Mushrooms, 
coriander, eucalyptus, juniper, lucerne and mistletoe de-
creased significantly (ranged 6%-48%). While elder and 
nettle extracts did not significantly decrease glucose dif-
fusion. Contrary to these findings, Büyükbalci and Sedef 
(2008) observed that the overall rates of glucose movement 
into external solution were higher than control for ten aque-
ous herbal tea extracts. None of the samples demonstrated 
significant inhibitory effects on glucose movement into 
external solution across dialysis membrane compared to 
the control. Further studies are required to elucidate in vitro 
effects regarding postprandial glucose absorptions and for 
improving glycemic control in diabetic subjects.
In conclusion, results of the present study suggest 
that Z. officinale rhizomes with antiglycating and anti-
diabetic/hypoglycemic properties might provide a viable 
approach, either food based or pharmacological, in the 
treatment of diabetic complications.
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